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Background: Multidrug punch cards are frame cards with 28 plastic cavities filled with
a patient’s oral solid medication. They are used in primary care to facilitate medication
management and to enhance adherence. Main criticism concerned handling difficulties
and fading knowledge about medication of patients using them. This study aimed at
exploring daily use, preferences, and adherence of primary care patients using multidrug
punch cards.
Methods: Community pharmacies in Switzerland recruited primary care patients using
multidrug punch cards. A mixed methods approach was applied with quantitative
interviews performed by telephone and qualitative interviews face-to-face.
Results: Of 149 eligible patients from 21 community pharmacies, 22 participated 2011
in the quantitative and 11 participated 2013/14 in the qualitative interview. Patients were
very satisfied with the multidrug punch cards and stated increased medication safety. All
considered adherence as very important. Self-reported adherence was 10 (median) on a
visual analog scale (0 = no intake, 10 = perfect adherence). The absence of package inserts
and predefined handling difficulties e.g., tablets spiking at removal were not perceived as
problems.
Conclusions: Patients are satisfied with the multidrug punch cards, feel safe, mostly have
no handling problems and adhere to their treatment. Trust in health-care professionals
and patients’ experiences emerged as key variables for initiating multidrug punch card use
and for medication adherence. This mixed methods study invalidates previous concerns
about disadvantages of multidrug punch cards. Health-care professionals should actively
recommend them for primary care patients with polypharmacy and poor adherence.
Keywords: pharmaceutical care, community pharmacy, medication adherence, primary care, dose-dispensing aids,
multidrug punch card, polypharmacy, mixed methods
INTRODUCTION
Medication management, i.e., the patient’s ability to self-
administrate her/his medication constitutes a major preoccupa-
tion in a patient’s life (Maddigan et al., 2003; Van Dooren et al.,
2010; Lecouturier et al., 2011). Physical and cognitive barriers
hinder patients from removing medication from the primary and
secondary packaging, from preparing it (e.g., handling a mea-
suring cup, tablet-splitting, etc.) and from administering it the
right way at the right time in the right dosage (Atkin et al., 1994;
Schoberberger et al., 2007; Van Geffen et al., 2010). Medication
administration errors including non-adherence and incorrect use
belong to the leading causes for adverse drug reactions and related
hospitalizations (Beijer and De Blaey, 2002; Gurwitz et al., 2003;
Field et al., 2007; Leendertse et al., 2008). Elderly patients with
polypharmacy for chronic diseases are at highest risk for such
adverse drug reactions (Kongkaew et al., 2008).
TheWorld Health Organization definedmedication adherence
as “the extent to which a person’s behavior—taking medication,
following a diet and/or executing lifestyles—corresponds with
agreed recommendations from a healthcare provider” (World
Health Organisation, 2003). An average of 50% of patients does
not take long-term medication as prescribed (World Health
Organisation, 2003), either intentionally (when the patient con-
sciously decides not to take the medication) or unintentionally
(when the patient is not able physically or cognitively to follow
his own intent of taking medication as recommended). Non-
adherence increases morbidity and mortality, decreases quality of
life, and raises healthcare costs (Hughes et al., 2001; Ho et al.,
2006, 2008; Cutler et al., 2007; Zed et al., 2008; Dragomir et al.,
2010; Roebuck et al., 2011). Strategies and aids to enhance adher-
ence have been of major interest (Bosworth et al., 2011). Dose-
dispensing aids such as multidrug punch cards and pillboxes have
been suggested for unintentionally non-adherent elderly patients
with complex medication regimen (Cramer, 1998; Hersberger
et al., 2013; Hugtenburg et al., 2013). Current literature reviews
state an effect of dose-dispensing aids on adherence and clin-
ical outcomes, but robust and reproducible studies are lacking
(Mahtani et al., 2011; Zedler et al., 2011; Boeni et al., 2014).
Several studies have described handling difficulties with the
use of dose-dispensing aids (Macdonald et al., 1977; Gould et al.,
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2009; Nunney et al., 2011; Adams et al., 2013). In one study,
six out of fifteen patients put the loose tablets from a dose-
dispensing aid back into a bottle because they could not handle
the device (Macdonald et al., 1977). Another study reported
that patients who elaborated their own medication management
system tended to return to it after initiation of a prefilled dose-
dispensing aid (Nunney et al., 2011). Such misuse is critical
for patient safety. Medication knowledge has been advocated as
essential for patient safety. Often, prepackaged dose-dispensing
aids are delivered directly to the patient’s home and thus were
observed to reduce contact between the pharmacist and the
patient. In connection, knowledge about self-administered med-
ication seemed to be poorer in patients with dose-dispensing
aids than in patients who manage their medication on their own
(Nunney and Raynor, 2001; Kwint et al., 2013). A recommen-
dation paper of the Royal Pharmaceutical Society criticizes the
distribution of dose-dispensing aids to all patients without assess-
ing their capabilities and needs (Royal Pharmaceutical Society,
2013). In Switzerland, one single criterion (intake of >3 differ-
ent medications) is required by the health insurance to supply
reimbursed dose-dispensing service (repackaging of solid oral
medication into dose-dispensing aids by a healthcare provider)
by the community pharmacy to primary care patients.
Two qualitative studies explored the views of patients using
various dose-dispensing aids (Lecouturier et al., 2011; Nunney
et al., 2011). Findings of these studies indicated that one group
of patients saw clear benefits in dose-dispensing aids, whereas
the other group felt patronized and restricted in liberty. Some of
the patients had handling problems with the devices and trou-
bles with identifying their medication. Both studies concluded
that future studies have to clarify which patients benefit most
from dose-dispensing aids and how to recognize them in primary
care.
Multidrug punch cards are disposable frame cards with plastic
cavities, sealed with a foil backing, with typically 28 compart-
ments, filled by pharmacy staff, by a specialized company or an
automated system (Figure 1). They provide a visual reminder for
medication intake, the possibility of adherence self-monitoring
and the saving of time, costs, healthcare resources (e.g., home
care nursing), andmedication waste. Multidrug punch cards were
introduced in Switzerland in 2002 together with a documentation
software for community pharmacies (Pharmis GmbH).
FIGURE 1 | Multidrug punch card. Front side (left): 28 plastic cavities
with visible packaged medication and labeling with patient and
pharmacy information. Back side (right): 28 cavities sealed with foil
and marked with indication of dosing time (morning, lunch, evening,
night; Monday–Friday); the adhesive medication plan labels brand
name, dose, administration number, dosing frequency, size, color,
imprint, batch number, and expiration date of each packaged drug.
All specifications are in German.
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We conducted a mixed methods study to assess experiences,
attitudes, and adherence of primary care patients using multidrug
punch cards in Switzerland. We aimed at investigating the pref-
erences of primary care patients using multidrug punch cards
in daily life, at compiling a profile of the primary care patient
benefitting most of the multidrug punch cards’ use and thus at
facilitating a targeted adherence interventions. The results should
advance the rational distribution of multidrug punch cards and
connected healthcare services.
MATERIALS AND METHODS
Quantitative interviews were performed in 2011 and qualitative
interviews were conducted sequentially in 2013/2014 to clarify the
results. A positive notification was obtained by the regional ethic
boards. Good Reporting of A Mixed Methods Study (GRAMMS)
guidelines were considered (O’Cathain et al., 2008).
RECRUITMENT AND INCLUSION CRITERIA
In 2011, all community pharmacies in the cantons of Basel-
Stadt, Baselland, Aargau, and Solothurn (Switzerland) deliver-
ing multidrug punch cards to primary care patients were asked
to participate in the recruitment of patients for the quanti-
tative interviews. Community pharmacies providing multidrug
punch cards to primary care patients in the cantons of Basel-
Stadt and Baselland were re-invited in 2013/2014 to recruit
patients for the qualitative interview. One pharmacist per phar-
macy was instructed for recruitment. Patients were eligible if
they had used multidrug punch cards for at least 3 months,
lived independently, administering medications without exter-
nal help, spoke German and were able to give informed con-
sent. The pharmacists decided upon eligibility of the patients
and recruited them by phone or face-to-face at their next visit
at the pharmacy. The study team received the contact details
of accepting patients and called them to fix a date for the
interview. Patient information and the informed consent form
were provided through the pharmacy or at the interview. For
both interviews, patients were approached in the same man-
ner, irrespective of participation in the first, quantitative inter-
view.
INSTRUMENTS
A quantitative questionnaire was developed containing five
domains (living situation, general questions about the mul-
tidrug punch cards, handling, design, andmedication adherence).
Answers were indicated as multiple choice, Lickert-scales, on
visual analog scales (VAS) or were open ended. The question-
naire was validated for feasibility, understandability and con-
sistency of the scales. The questionnaire comprised 31 ques-
tions and took 30min to conduct. Demographic parameters
included age, sex, living situation, education, status of employ-
ment, and number of medications. Adherence was measured
through patient self-report on a VAS ranging from 0 (taking
no medication) to 10 (taking all prescribed medication every
day at the right time). The term “medication adherence” is
not colloquially used in Swiss German. We therefore replaced
it with “fidelity to therapy” [Therapietreue], which we sug-
gested to be more understandable. The term was explained
to the patients before patient self-report of adherence by the
VAS and discussion about importance of adherence was con-
ducted.
A qualitative topic guide was constructed upon the results of
the quantitative questionnaire with themes that remained unclear
or contradictory. The topic guide and the course of the inter-
view were piloted with two patients who were not included into
the final analysis. Adoption of the multidrug punch cards, accep-
tance, use in everyday life, design, andmedication adherence built
the five domains. Subtopics were outlined with 19 pre-worded
questions. Demographics and adherence were asked in the same
manner as in the quantitative interview. Both, the quantitative
questionnaire and the qualitative topic guide were applied as
interviews. After interviews had been held, the current medica-
tion plan was obtained from the corresponding pharmacies.
The quantitative interview was conducted by telephone
after informed consent was received by post. One interviewer
performed the interview, reading out the questions and the
possible answers of the questionnaire. Immediate feedback was
requested from the interviewed patient for assurance of ticking
the right box.
The qualitative interview was held face-to-face at the patient’s
home or at the pharmacy in a separate room. FB led the interview
and another researcher asked in-depth questions. Each domain
was introduced to the patients by a general open-ended question
to allow the patients to answer freely. Subtopics that remained
untouched were then explored by further questions. The order
of the domains and questions followed the patient’s answers.
The interviews were held in Swiss German and were audiotaped.
One research assistant (NR) orthographically transcribed the
recordings in German language, preserving dialect expressions.
All transcriptions were double-checked by FB.
ANALYSIS
The quantitative interviews were analyzed descriptively by using
Microsoft Excel 2013 for Windows (Microsoft Corporation,
Redmond, WA, USA). Answers to open questions were catego-
rized and analyzed quantitatively. Missing data were excluded
from the analysis. Numbers of valid answers are given for each
question.
Transcriptions of qualitative interviews were transferred to
MAXQDA V. 11 for Windows (VERBI GmbH, Berlin, Germany).
Data were analyzed analogously to a five-stage “framework
approach” developed for applied qualitative research (Pope et al.,
2000; Lecouturier et al., 2011). A coding framework was consti-
tuted by preliminary coding of five interviews. Domains related
to the original topics were structured as main codes and emergent
themes formed sub-codes. After verification, the coding frame-
work was applied to all interviews. Coding was performed man-
ually line-by-line by FB. Codes of all interviews were grouped for
detection of associations and patterns. Quotations were selected
to illustrate the analysis. They were translated into English by
FB and checked by a native English speaker. Original German
transcriptions of the quotations are listed in the Supplementary
Material.
Quantitative and qualitative data are presented in direct rela-
tion to each other in the Results’ section and were integrated by
FB on the level of interpretation. Qualitative data were used to
complete and explain findings from the quantitative interviews.
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RESULTS
DEMOGRAPHICS
In 2011, 33 of 266 community pharmacies in the cantons of
Basel-Stadt, Baselland, Aargau, and Solothurn delivered mul-
tidrug punch cards, mainly to nursing home patients. Of the
25 pharmacies supplying primary care patients, 21 participated
in the recruitment of the patients for the quantitative interview.
They supplied a total of nquant = 149 patients, of whom 25 (17%)
were contacted by the study team and 22 (15%) consented to
perform the quantitative interview.
In 2013/2014, 13 of 124 community pharmacies in the cantons
of Basel-Stadt and Baselland supplied primary care patients with
multidrug punch cards and 6 participated in the recruitment of
the patients for the qualitative interviews. Of a total of nqual = 60
patients, 18 (30%) were recruited and 16 (27%) consented to per-
form the qualitative interviews. Five patients had to be excluded
from the analysis, two because they participated in the pilot study,
two because of language difficulties and one because of the use of
a dose-dispensing aid other than multidrug punch cards. Reasons
for exclusion by the pharmacist for the quantitative and qual-
itative interviews were (nquant/nqual): cognitive or psychological
barrier 30/16; participation rejected 27/13; home care 25/4; lan-
guage barrier 19/11; patient unreachable 6/6; multidrug punch
card use for less than 3 months 6/3; terminal medical condition
2/0; deceased 2/2; multidrug punch cards abandoned 1/0; reason
unknown 6/3. Patient demographics are listed in Table 1. Mean
durations of the quantitative and qualitative interviews were 28.5
(SD ± 7.5) and 42.8 (SD ± 14.2) min, respectively.
REASON TO RECOMMEND MULTIDRUG PUNCH CARDS
According to the quantitative interviews, multidrug punch cards
were recommended by pharmacists in 54% of the cases, by physi-
cians in 18%, by relatives in 14%, and by others in 14%. Of the
Table 1 | Demographics of patients participating in the quantitative
and in the qualitative interviews.
Patient Quantitative
interview
Qualitative
interviewdemographics
Participants, n 22 11
Age, median 71 (37–96) 76 (27–91)
(range) [years]
Sex, n Female 14 5
Male 8 6
Living situation, n Alone 13 10
With partner 9 1
Education, n No school graduation 2 2
Primary school 19 8
University 1 1
Status of
employment, n
Employed
Retired/unemployed
1 0
21 11
Numbers of
medications,
median (range)
In multidrug punch
cards
7 (4–13) 7 (4–12)
Additional (outside
multidrug punch
cards)
1 (0–4) 1 (0–3)
16 patients who had the multidrug punch cards recommended
by a pharmacist or a physician, 14 remembered one or sev-
eral reasons: (new) prescription of numerous medications and/or
complex regimen (n = 7), facilitation ofmedicationmanagement
(n = 6), poor adherence (n = 6), hospital discharge (n = 3), and
medication abuse (n = 2).
Qualitative interviews largely confirmed these reasons. The
medical condition was named as principal reason which finally
resulted in getting multidrug punch cards (n = 4). The same
four patients, who stated that they were confused with their
medication or had difficulties in handling it, also declared that
non-adherence was a reason for the recommendation of the mul-
tidrug punch cards. Difficulty/confusion: “I always have messy
cupboards xxx. I’ve always had a box with one pill here, one pill
there. Packaged like this [in regular packaging], right? Then I just
did “tschak, tschak, tschak” back and forth. And in time it seemed
to me, it’s not the best solution, is it.” (P7) [xxx = garbled speech,
unable to make an educated guess]. Non-adherence: “Sometimes
it’s also happened that I’ve forgotten one [tablet] or so.” (P7). These
patients mentioned their problems in the community pharmacy
or to a relative, which led to the recommendation of multidrug
punch cards. Four patients received the multidrug punch cards
on prescription or by arrangement between the general physician
(GP) and the pharmacist. Two of them did not remember having
talked about it to the GP or the pharmacist prior to the initiation
of the multidrug punch cards. One patient explained that it was
his own idea to save money, because the size of packages often
did not fit his needs. The packaging was proposed as solution by
the GP. “[. . . ] either they [the pharmacy] make packs with only 10
[tablets], and then this doesn’t really go far. Or they [the pharmacy]
make a pack with 50 or 100 [tablets] and I don’t need them either.
And then, there’s a lot lost. And that way [with the multidrug punch
cards], I really have only the medication that I need.” (P2).
ADVANTAGES AND DISADVANTAGES OF MULTIDRUG PUNCH CARDS
In the quantitative interviews, all 22 patients felt well cared for by
the pharmacy. All were satisfied with the multidrug punch cards,
20 of them very much. Facilitation of medication management
and the reminding ofmedication intake were themain advantages
mentioned. Overall, 67 advantages and 12 disadvantages were
named (Table 2). Twenty patients liked the design of the mul-
tidrug punch cards and agreed fully that it was clearly arranged.
The orientation according to the written dosing times was judged
as very easy by 21 patients and as easy by one. However, the
patients stated uniformly that the functionality was more impor-
tant than the design. The multidrug punch cards were rated as
practical and very robust by all 22 patients.
The satisfaction was also high in the qualitative interviews with
55 passages coded with positive expressions about the multidrug
punch cards [e.g., “This is marvelous!” (P1)]. There were no cor-
responding negative remarks. Most patients said that they much
preferred the multidrug punch cards to their prior medication
management system. It was a facilitation, not only for medication
management, but also for their life: it was less time consum-
ing, they did not have to reflect which “box” to use at which
dosing times and they did not have to store numerous medica-
tion boxes. “This [multidrug punch cards] really simplifies my life!”
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Table 2 | Advantages and disadvantages named by all 22 patients of
the quantitative interview in an open-ended question.
Advantages Disadvantages
Facilitation of medication
management
22 Difficult medication
removal
5
Reminder for medication
intake
14 Missing package insert 3
Clear design 7 High refill frequency 2
Control 6 Waste 1
Medication safety 4 Missing confidentiality 1
Organization 4
Communication 2
Facilitation of therapy
adjustment
2
Mentioned once: recycling of
medication, space-saving,
hygiene, documentation,
home delivery, rationing
6
Total 67 12
(P1). “Again, one concern less for me!” (P5). Patients also high-
lighted the clarity and order of the multidrug punch cards. The
layout helped them to orientate themselves. Interviewer: “And
why do you like it, when it [the medication] is packaged like this
[in the multidrug punch cards]?”—Patient: “You have an overview.
[. . . ]” (P8). Few comments concerned the high-level hygiene and
the suitability for old and/or forgetful people. Only four negative
comments were issued by three patients: the sound of the mul-
tidrug punch cards while handling was displeasing, a long sheet
with the medication plan glued on the back was unpractical while
removing medication, the assumption that the handling could be
difficult for people with disabilities and the lack of package insert
and information to identify the tablets. “The disadvantage, I find
a bit is that you don’t have an overview of the tablets. Now, I really
can’t. . .. Where there is a heart on it [the tablet], I know it is for
the heart somehow, but on the whole, I do not know what I here
[take]. . .. Well, everything is written in the back, isn’t it, for me.
I don’t know if they do that in general or not?” (P4). This com-
ment was stated by a patient who also criticized that he could
not understand the information of the medication plan glued on
the back, he thought it was written in Latin. On the other hand,
the lack of package insert did not trouble other patients and was
appreciated as an advantage by several patients.
HANDLING OF THE MULTIDRUG PUNCH CARDS
In the quantitative interviews, 21 out of 22 patients were very sat-
isfied with the handling of the multidrug punch cards. Nineteen
patients pushed the medication out with their fingers. Of five
patients cutting the foil on the backside, four seldom or never
had trouble in pushing out the tablets. In total, 14 (64%) patients
indicated never having trouble with removing medication from
the multidrug punch cards. Eight patients had technical or phys-
ical difficulties: tablets spiked at removal (n = 5); tablets stuck in
the cavity at removal (n = 4); dexterity problems (n = 3); cavity
too fully loaded (n = 1).
During the qualitative interviews, patients were asked to
demonstrate with a demo multidrug punch card how they
removed their medication. All 11 patients removed the mock
medication without trouble, but sometimes it spiked. Although
some patients admitted that this happened from time to time with
their own multidrug punch cards too, they mostly did not see
it as a drawback. Some of the patients described problems with
removing medications at the very beginning of multidrug punch
card use, but they developed their own strategy to overcome these
problems. Most patients had not been instructed how to use the
multidrug punch cards or did not remember it. They negated the
need for it, because they found the multidrug punch cards self-
explaining. Four patients reported that they daily removed the
content of the cavities in advance into a separate little box or bowl.
This was practical to them because they kept themedication ready
and could not mix it up, or they had it in their pocket in case they
left home. One patient was sure that she would forget the intake
in the morning, if she did not prepare the dose the evening before.
“Because I have to prepare them, otherwise I would really. . ., I have
to tell you honestly, I would forget them [themedication].” (P8). Two
patients told that theymanipulated themultidrug punch cards for
their purpose. The main motivation was cutting the size for stor-
age or transport. “[. . . ]. If I know, of course, I will leave for three
days, then I cut it [multidrug punch card] here.” (P2). One patient
also pushed medication into the cavities or took some of the filled
medication out if there was a short-term change in medication
therapy. She did not report these therapy changes to the phar-
macy until she was sure it was fixed. “[. . . ]. And after this, just
once for this evening I did it, so that I don’t have to mess around
for a long time, I took the two [tablets] that I have to take anyway,
I pushed them in here and the blue one I already pushed out [of
the multidrug punch card]. That’s how I work with the blister [=
multidrug punch card].” (P1).
SAFETY ISSUES
In the quantitative interviews, safety and control were named by
four and six patients, respectively, as an advantage of the mul-
tidrug punch cards (Table 2). All 22 patients stated that they felt
safer in medication management with the multidrug punch cards
than without. All patients agreed fully that they could read the text
with the information written and glued on the back of the mul-
tidrug punch cards without problems. Three patients admitted
that they never read this text. Three patients named the missing
package insert as a disadvantage.
The topic safety was explored in-depth in the qualitative inter-
views. All 11 patients confirmed that the multidrug punch cards
made them feel safe in managing medication. The main reasons
were the overview of their medication and to be in control of
medication intake. It was very important for them to be sure
they had the right medication at the right time. “Yes, I would say
there is a kind of safety in it [multidrug punch cards]. Then I’m
sure I took the right one, here.” (P2). Some patients mentioned
in that context that they believed the medication filling to be
correct and that they could rely on the controls of the health-care
professionals. Nevertheless, all 11 patients reported that they
controlled the tablets immediately after removal by number,
shape or color. Two patients felt safe because the medication
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was incorporated in a package that was hygienic and robust. In
relation to medication knowledge, the patients could be divided
in two groups (Figure 2). Group A was confident to know the
name and indication of their medication, could more or less
identify the tablets in the multidrug punch cards and stated
that they did not need further information or a package insert.
Group A/Knowledge: “I know exactly what I have to take, [. . .
].” (P5). Group A/Package insert: “Because if I have to read the
package insert, either I have to or I want to, I suffer from everything
that is written there. And I don’t want that at all.” (P1). Group
B did not know the name and indication of their medication
and could mostly not identify the tablets. All patients of Group
B except one did not want more information because they
declared not to understand it. The package insert was refused
quite fiercely by some patients and was named as a reason for
denied medication intake. All patients of group B explained that
they were faithful to the pharmacy for years and that they trusted
health-care professionals. Trust and fidelity to the pharmacy
also coincided with statements of perfect medication adherence.
Group B/Knowledge: Interviewer: “How well do you know which
tablet is which, for example?” Patient: “I don’t know.” (P9). Group
B/Package insert: Patient: “But what the other one is, I don’t
know.”— Interviewer: “You don’t know it. Would you like to know
it then? So, do you mind not knowing it?”—Patient: “Well, I don’t
know if I would actually like to know it or not.”—Interviewer: “That
means this fits for you then?”—Patient: “You know, this would. . .
if, if this was something that. . . This would concern me very much.
[. . . ]” (P8). Group B/Package insert/trust and fidelity: “[. . . ].
I trust you and the physicians. I’m not interested in this because I
don’t understand it anyway. What’s in it and what’s written on it
[in/on the multidrug punch card] and so. No, I never look at it.”
(P3). The medication plan glued on the backside of the multidrug
punch cards was very much appreciated and was declared to
contain enough information about the medication and the user.
Some patients saw it as a major advantage in safety because they
could give the correct names and dosages of their medication to
physicians at first consultation or at admission to the hospital.
Two patients told that they requested oral and written infor-
mation on medication from the pharmacy if they had specific
questions. All 11 patients described their contact to the pharmacy
to be very good and the pharmacy team to be very friendly.
ADHERENCE
In the quantitative interviews, patients indicated that the mul-
tidrug punch cards were a tool to remind them of medication
intake. Compared to their prior medication management system,
21 patients rated a relative improvement of +37% (SD ± 43%)
for taking adherence and 19 patients rated a relative improvement
of +38% (SD ± 43%) for timing adherence after the initia-
tion of multidrug punch cards. One patient estimated his timing
adherence to be 13% worse with the multidrug punch cards than
without. Median self-reported adherence of the 33 patients par-
ticipating in quantitative and qualitative interviews was 10 on the
VAS (range 3–10).
In the qualitative interviews, all 11 patients stated that they did
not know the term adherence [fidelity to therapy, Therapietreue],
but three patients could imagine the rough sense of it. “Yes, I stick
to the rules. Which I get ordered, now about the therapy, sort of. . .
yes. I do what I should and not. . .. Faithful to therapy, like this. Xxx.
If you now get medication to calm down, if you. . . have a fit. Then
I would say, fidelity to therapy is really if you just take it at the right
moment.” (P6). Others related it to physical therapy because in
Swiss German the term “therapy” [Therapie] theoretically stands
for various kinds of therapy, but is colloquially often used for
physical therapy. Some patients had no idea of the meaning of the
term “fidelity to therapy.” Two patients remembered that they had
a talk with their health-care professionals about adherence, but
the majority thought this was self-evident and that they did not
FIGURE 2 | Adherence elements emerging from qualitative interviews.
Although all patient stressed perfect adherence, statements of Group A
allowed margins for time of medication intake (= near to perfect adherence).
“Medication knowledge” relates to a patients’ confidence to appoint the
name and/or the indication of the medication and/or to identify the tablets
(ADRs, adverse drug reactions; hcp, health-care professionals).
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need further explanations. All 11 patients declared that medica-
tion adherence was very important for them and emphasized their
willingness to be adherent. As reasons they indicated that it made
sense to follow the physician’s directions, that they would benefit
from the therapy and that they would suffer from medical conse-
quences if they were non-adherent. One patient even stated that
pharmacotherapy was existential for her. All patients who feared
medical consequences of non-adherence had a history of an
adverse medical event (e.g., heart attack) or suffered from a med-
ical condition, which they had to keep under strict control (e.g.,
diabetes mellitus, epilepsy). “I know it [the medication] holds off a
lot, when you had two heart attacks, then you know what it means
to take medication. Then you really take it [the medication].” (P9).
“Well, what do I want? There is nothing else for it. It only benefits
me, if I take it, right? I don’t want to sit in the hospital again.” (P8).
Statements about adherence matched Groups A and B defined in
the Safety’s section. Patients from Group A were more liberal and
reported that they were fine with a margin for time of medica-
tion intake. Patients from Group B were anxious about leaving
out one tablet or taking one dose too late since they were sure to
sense immediate consequences. “If I did not take them, I would feel
it. So, I would have to go soon, most likely. . . , so maybe the second
day at most [after missing a tablet], I would already have to go to the
physician and say: ‘I don’t feel well anymore’. So yea, I would feel it.”
(P10). Three patients believed that they would forget medication
intake if they had to prepare the medication themselves out of the
regular packaging, if the multidrug punch card was stored at a
hidden place, or if there were more dosing times. Most patients
who admitted that they forgot medication intake with their prior
medication management system also forgot intake with the use of
the multidrug punch cards, but much less than before. The visu-
alization of the doses would reveal their omission and allow them
to make up the intake. One patient had problems remembering
the short-term therapy that she was managing besides the mul-
tidrug punch cards. Three patients were absolutely sure that they
never forgot medication intake. Strategies to remember medica-
tion included defining an eye-catching place of storage for four
patients, setting an alarm for two patients and embedding med-
ication taking into a ritual or daily routine for four patients. All
four patients who had defined a special place of storage reported
always seeing it and therefore remembering medication intake.
Patients who had the medication intake embedded in their daily
routine told that they did not have to remember medication tak-
ing as a separate action, it was more like an automatism within
their normal activities. They also did not need to control the
multidrug punch cards to ensure timely intake. “It is, it’s like auto-
matic, right?When I’m sitting, havingmy breakfast at the table, then
I just do it and then it’s done. And then I put it [the medication] into
the plate and the matter is settled.” (P5). “I always take all of them. I
always take them how I have to, I don’t have to control it.” (P9). For
most patients control of intake was an additional step of safety.
“But here [with themultidrug punch card] you have control after all!
Here you have it, you are sure that you took the right thing [medica-
tion].” (P11). “I see it at first sight. I had it, I took it, I know it.” (P2).
DISCUSSION
We combined quantitative and qualitative methods in an explana-
tory way to investigate the profile of multidrug punch card users
in-depth, and the influence of the dose-dispensing aid on their
adherence. Our primary care patient using multidrug punch
cards reports high level of satisfaction with the multidrug punch
cards, few handling difficulties and highmedication safety. She/he
declares currently highest medication adherence and improved
adherence compared to her/his prior medication management.
Our results support the assumption that unintentionally non-
adherent patients represent a target population for dose dispens-
ing aids (Cramer, 1998; Hugtenburg et al., 2013) and highlight
some key variables which health-care professionals may assess
while recommending multidrug punch cards to patients with
polypharmacy.
The typical independent primary care patient accepting to use
multidrug punch cards is over 70 years old, has a low education
grade, is retired, lives alone, favors tidiness, rituals, and daily rou-
tines and is unable or reluctant to leave home. She/he trusts the
health-care professionals, is a regular customer of the same com-
munity pharmacy, is motivated to conduct a healthy life and has a
feeling of high necessity for medication. The association of adher-
ence with the necessity for medication intake is well-known and
has been used as an integral part of the “believes about medicines
questionnaire,” an instrument to assess adherence (Horne and
Weinman, 1999).
Our patients much preferred the multidrug punch cards
to their prior medication management and reported improved
adherence of even +37% after the initiation of the device.
Significantly increased adherence was also demonstrated by five
out of six randomized controlled trials investigating the use of
multidrug punch cards in primary care patients (Crome et al.,
1982; Ware et al., 1991; Lee et al., 2006; Schneider et al., 2008;
Valenstein et al., 2009). Additionally, in two of these studies (Lee
et al., 2006; Schneider et al., 2008) cardiovascular patients with
polypharmacy achieved significantly improved clinical outcomes
(e.g., blood pressure, LDL cholesterol). Thus, major improvement
of adherence and of associated outcomes by the use of multidrug
punch cards are likely.
In our study, patients claimed their perfectly adherent behav-
ior to be motivated by a personal experience of benefit if
they adhered to the physician’s orders or by a fear of med-
ical consequences if they did not. These findings correspond
to the role of patients’ experiences denoted as crucial for
clinical safety and effectiveness (Doyle et al., 2013). Trust
toward the pharmacy emerged also as a reason for high adher-
ence, since the participants expressing trust toward health-care
professionals most explicitly, were most accurate with their
medication plan. This attitude is characterized as the “pas-
sive medication user,” representing one out of three differ-
ent types of medication intake-behavior (Dowell and Hudson,
1997). We thus suggest that the population of “passive med-
ication users” could be a target group for the use of mul-
tidrug punch cards. If we add that high fidelity to the phar-
macy is associated with increased medication adherence and
decreased adverse drug reactions (Marcum et al., 2014), we
can suppose that multiple key variables at different levels
permit to reach a perfect medication intake behavior (trust
in the institution/health-care professionals; perceived benefits
of the management system; fear of negative consequences)
(Figure 2).
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Although multidrug punch cards do not feature an explicit
reminder function, its storage at a strategic visible place helped
the patients to remember medication intake. In particular, it
allowed immediate visual control of the intakes, the performed
ones as well as the forgotten ones. An advanced strategy seems the
integration of the medication intake into daily routine to become
an “automatism;” the patients even did not have to think about
medication intake. Habits and routines have long been described
to be beneficial for general adherence (Reach, 2005; Kripalani
et al., 2010) as well as for dose-dispensing aids (Lecouturier et al.,
2011). As a consequence, recommending multidrug punch cards
should include an assessment of the patients’ daily habits and
routines.
Reasons for recommendation of multidrug punch cards and
major advantages assessed in our study e.g., facilitation of medi-
cation therapy and improvement of adherence, mostly coincided
with results of two qualitative studies on primary care patients
using different types of dose-dispensing aids (e.g., pillboxes, mul-
tidrug punch cards, etc.) (Lecouturier et al., 2011; Nunney et al.,
2011).
Absence of medication information—due to the dispensing of
multidrug punch cards without package inserts—was of minor
importance in the quantitative interviews. The in-depth explo-
ration of the qualitative interviews confirmed that the patients
were satisfied with a minimum of medication information. Only
two patients requested written or oral medication information
from the pharmacy. These findings might appear controversial,
since a lack of medication information has been related to a
reduction of knowledge resulting in a dangerous loss of skills
and autonomy of the patient (Nunney and Raynor, 2001; Nunney
et al., 2011; Royal Pharmaceutical Society, 2013). Inversely, good
medication knowledge was suggested to reduce inappropriate
medication administration, adverse events and non-adherence,
and hence to increase medication safety (Kim et al., 2006; Field
et al., 2007; Pernod et al., 2008; Chan et al., 2013). However, these
investigations were not performed within a population using
multidrug punch cards. Since their use spares the handling of reg-
ular packaged medication, a different type of knowledge seems
needed by those patients than the information contained in pack-
age inserts. Our assumptions are strengthened by a recent study
showing that patients over 65 years with dose-dispensing aids
were significantly more adherent (n = 119) but less knowledge-
able than patients who managed their medication by themselves
(n = 96) (Kwint et al., 2013). Finally, sincemultidrug punch cards
per se reduce potential errors of administration to a minimum, a
relation to medication knowledge is unlikely.
Handling problems (e.g., difficulty in removing medication,
confusing inscriptions when to take the medication, etc.) were
claimed to constitute a major reason for reduced medication
safety with dose-dispensing aids (Macdonald et al., 1977; Gould
et al., 2009; Nunney et al., 2011). Consequently, the small number
of handling problems in the quantitative interviews was sur-
prising. However, the qualitative interviews confirmed the first
findings and revealed a major contribution of multidrug punch
cards to the patients’ feeling of medication safety. The clear design
of the multidrug punch cards assured its safe use. Hence, for most
patients instruction was dispensable.
For practice, our study implies that medication manage-
ment and non-adherence should be addressed actively through
health-care professionals. The profiling enables selecting the right
patients, provides arguments for recommendation and points
out relevant issues for advancement of dose-dispensing service.
Initially, trust between the patient and the health-care profes-
sional has to be established and patients’ experiences and habits
should be included into adherence counseling. While recom-
mending multidrug punch cards, pharmacists should emphasize
the facilitation of medication management and the increased
medication safety. Based on our results, other strategies to
advance dose-dispensing service and increase safety might be
considered e.g., regular medication review of the packaged medi-
cation by a pharmacist (Kwint et al., 2011), giving instruction on
multidrug punch cards if necessary (anticipation of handling dif-
ficulties, integration into life-style, reminder strategies), inclusion
of short-termmedication into the packaging, detailed instruction
of separate medication, and regular contact between pharmacy
and patient.
STRENGTHS AND LIMITATIONS
The strength of this study was the deeper explanation of ambigu-
ous quantitative data through qualitative interviews. To our
knowledge, this is the first study with a mixed methods approach
in the field of dose-dispensing aids and their impact on medica-
tion adherence.
Our study results are limited through several points. First,
our study sample is small. On one hand, this is due to the
effective small number of primary care patients, who are using
multidrug punch cards without external help. In Switzerland,
multidrug punch cards were originally intended for the supply
of nursing homes. Only in the last few years, they were rec-
ommended to primary care patients. Further, the primary care
patients selected by the pharmacists as multidrug punch card
users really were the target group for this type of adherence aid
(cognitive or psychological barrier, home care, language barrier),
but turned out to be inadequate for our study. On the other
hand, about half of the adequate patients refused study par-
ticipation. Telephone interviews constituted a major barrier for
recruitment. Conducting interviews at home or at the pharmacy
were more acceptable. Second, the high level of satisfaction may
reflect a selection bias. We can assume that patients unsatisfied
with the multidrug punch cards might not have been willing to
consent for interviews, especially if invited by the provider of
the unsatisfactory device. Further, the recruiting pharmacist may
have approached satisfied users among her/his patients to take
part in the study. The problem-free handling of the multidrug
punch cards that we observed might be the result of a further
selection bias, since we excluded cognitively impaired patients
who are known to experience difficulties with the handling of
any medication packaging (Atkin et al., 1994; Adams et al., 2013).
Additionally, because our participants had to use the punch cards
at least 3 months for inclusion, initially encountered difficulties
may have been solved already. Third, reporting and interviewer
biases may have interfered with study results. Since there were no
differences observed by location of interview, the conduction of
the interviews at the pharmacy does not seem to have influenced
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the patients’ answers. Fourth, adherence was measured through
patient self-report which has been described not to be fully reli-
able and often overestimated (Zeller et al., 2008). However, the
conformity with similar studies (Lee et al., 2006; Kwint et al.,
2013) endorses our results. Fifth, this study represents the views
of patients solely using multidrug punch cards and cannot be
generalized to patients using other dose-dispensing aids.
OUTLOOK
Future research should aim at developing studies with larger
populations to enable generalization. The development of an
assessment tool for non-adherent patients to provide targeted
interventions should be a priority. Clarification of the impact
of multidrug punch cards on patient-oriented outcomes should
be aspired. Younger patients with complex medication regimen
should be interviewed about their preferences to clarify the bene-
fit of multidrug punch cards for additional populations.
CONCLUSIONS
Characteristics of primary care patients using multidrug punch
cards include age over 70 years, low education grade, living alone,
appreciation for tidiness and daily routine, trust in health-care
professionals, fidelity to pharmacy, and motivation for a healthy
lifestyle and medication adherence. The patients are satisfied
with the multidrug punch cards, feel safe, mostly have no han-
dling problems and adhere perfectly to their treatment. Multidrug
punch cards constitute a simplification for their lives, offer a clear
overview of hygienically packaged medication, a reminder func-
tion and a possibility for adherence monitoring. Key variables for
initiating multidrug punch card use and for medication adher-
ence are trust in health-care professionals and patients’ experi-
ences. This mixed methods study attenuates previous concerns
about disadvantages of multidrug punch cards. Hence, health-
care professionals should actively recommend them for primary
care patients with polypharmacy and poor adherence.
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